Cargando…

Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience

Detalles Bibliográficos
Autores principales: Rose, Tracy L., Weir, William H., Mayhew, Gregory M., Shibata, Yoichiro, Eulitt, Patrick, Uronis, Joshua M., Zhou, Mi, Nielsen, Matthew, Smith, Angela B., Woods, Michael, Hayward, Michele C., Salazar, Ashley H., Milowsky, Matthew I., Wobker, Sara E., McGinty, Katrina, Millburn, Michael V., Eisner, Joel R., Kim, William Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023585/
https://www.ncbi.nlm.nih.gov/pubmed/35277660
http://dx.doi.org/10.1038/s41416-022-01781-y
_version_ 1784690381957365760
author Rose, Tracy L.
Weir, William H.
Mayhew, Gregory M.
Shibata, Yoichiro
Eulitt, Patrick
Uronis, Joshua M.
Zhou, Mi
Nielsen, Matthew
Smith, Angela B.
Woods, Michael
Hayward, Michele C.
Salazar, Ashley H.
Milowsky, Matthew I.
Wobker, Sara E.
McGinty, Katrina
Millburn, Michael V.
Eisner, Joel R.
Kim, William Y.
author_facet Rose, Tracy L.
Weir, William H.
Mayhew, Gregory M.
Shibata, Yoichiro
Eulitt, Patrick
Uronis, Joshua M.
Zhou, Mi
Nielsen, Matthew
Smith, Angela B.
Woods, Michael
Hayward, Michele C.
Salazar, Ashley H.
Milowsky, Matthew I.
Wobker, Sara E.
McGinty, Katrina
Millburn, Michael V.
Eisner, Joel R.
Kim, William Y.
author_sort Rose, Tracy L.
collection PubMed
description
format Online
Article
Text
id pubmed-9023585
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-90235852022-04-28 Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience Rose, Tracy L. Weir, William H. Mayhew, Gregory M. Shibata, Yoichiro Eulitt, Patrick Uronis, Joshua M. Zhou, Mi Nielsen, Matthew Smith, Angela B. Woods, Michael Hayward, Michele C. Salazar, Ashley H. Milowsky, Matthew I. Wobker, Sara E. McGinty, Katrina Millburn, Michael V. Eisner, Joel R. Kim, William Y. Br J Cancer Correction Nature Publishing Group UK 2022-03-11 2022-05-03 /pmc/articles/PMC9023585/ /pubmed/35277660 http://dx.doi.org/10.1038/s41416-022-01781-y Text en © The Author(s), under exclusive licence to Springer Nature Limited 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Correction
Rose, Tracy L.
Weir, William H.
Mayhew, Gregory M.
Shibata, Yoichiro
Eulitt, Patrick
Uronis, Joshua M.
Zhou, Mi
Nielsen, Matthew
Smith, Angela B.
Woods, Michael
Hayward, Michele C.
Salazar, Ashley H.
Milowsky, Matthew I.
Wobker, Sara E.
McGinty, Katrina
Millburn, Michael V.
Eisner, Joel R.
Kim, William Y.
Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience
title Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience
title_full Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience
title_fullStr Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience
title_full_unstemmed Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience
title_short Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience
title_sort correction to: fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023585/
https://www.ncbi.nlm.nih.gov/pubmed/35277660
http://dx.doi.org/10.1038/s41416-022-01781-y
work_keys_str_mv AT rosetracyl correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience
AT weirwilliamh correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience
AT mayhewgregorym correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience
AT shibatayoichiro correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience
AT eulittpatrick correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience
AT uronisjoshuam correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience
AT zhoumi correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience
AT nielsenmatthew correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience
AT smithangelab correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience
AT woodsmichael correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience
AT haywardmichelec correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience
AT salazarashleyh correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience
AT milowskymatthewi correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience
AT wobkersarae correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience
AT mcgintykatrina correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience
AT millburnmichaelv correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience
AT eisnerjoelr correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience
AT kimwilliamy correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience